Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 17201-17202 [E9-8479]
Download as PDF
Federal Register / Vol. 74, No. 70 / Tuesday, April 14, 2009 / Notices
¨
10. E Ozarslan, CG Koay, PJ Basser.
Double-PFG diffusion-diffraction in
ellipsoidal pores. In 9th International
Bologna Conference on Magnetic
Resonance in Porous Media 2008;
p. 115.
Licensing Contacts
Uri Reichman, PhD, MBA; 301–435–
4616; UR7a@nih.gov; John Stansberry,
PhD; 301–435–5236;
stansbej@mail.nih.gov.
Patent Status
U.S. Provisional Application No. 61/
087,968 filed 11 Aug 2008 (HHS
Reference No. E–276–2008/0–US–01).
Advantages
The three inventions described above
and collectively offered for licensing
offer a non-invasive, painless means for
measurement quantities such as the
axon diameter distribution (ADD) and
significant improvements in sensitivity
and robustness to existing MRI methods,
in particular for imaging of the Central
Nervous System, and for in vivo
measurement of microanatomical
(histological) features of nerves (and
possibly muscles) that are critically
important in medicine and in particular
in neuroscience. Furthermore, ADD is
altered in abnormal development
(possibly even in autism), in
degenerative process (e.g., aging,
alcoholism, Alzheimer’s disease) and
diseases such as ALS (Lou Gehrig’s
disease) and thus the improved
sensitivities offered by the subject
inventions is of utmost significance for
public health.
Development Status
These inventions are fully developed.
Market
The market for MRI in human
diagnostics is huge and rapidly growing.
The race to improve the sensitivities of
MRI measurement and to enhance the
capabilities of measuring and examining
fine structures in general, and in
neuroscience in particular is of
significant magnitude. The three
inventions described above may
collectively offer significant commercial
opportunity to MRI companies.
The market for medical imaging
equipment industry is approximately
$9.0 billion dollars now and has been
growing by approximately 7.6%
annually. MRI instrumentation
constitutes a significant portion of this
market.
Related Technology
U.S. Patent No. 5,539,310 issued 23
Jul 1996—‘‘Method and System for
Measuring the Diffusion Tensor and for
Diffusion Tensor Imaging’’ (HHS
Reference No. E–203–1993/0).
Licensing Status
Available for licensing.
VerDate Nov<24>2008
16:39 Apr 13, 2009
Jkt 217001
Collaborative Research Opportunity
The Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, Section on Tissue
Biophysics and Biomimetics, is seeking
statements of capability or interest from
parties interested in collaborative
research to further develop, evaluate, or
commercialize novel MRI methods to
probe tissue structure and organization,
particularly for neuroimaging
applications. Please contact Alan
Hubbs, PhD at 301–594–4263 or
hubbsa@mail.nih.gov for more
information.
Dated: April 7, 2009.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E9–8475 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials in Motor
Neuron Disease.
Date: April 20, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call)
Contact Person: Shanta Rajaram, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division Of Extramural
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
17201
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC9529, Bethesda, MD 20852, (301) 435–
6033, rajarams@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8471 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ‘‘Comparative
Evaluation of Assisted Reproductive
Technologies and Birth Outcomes’’.
Date: May 6, 2009.
Time: 2 p.m. to 3 p.m.
Agenda: To provide concept review of
proposed concept review.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
PhD, Scientific Review Administrator,
Division of Scientific Review, National
Institute of Child Health and Human
Development, 6100 Executive Boulevard,
Room 5b01, Bethesda, MD 20892–9304, (301)
435–6680, skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\14APN1.SGM
14APN1
17202
Federal Register / Vol. 74, No. 70 / Tuesday, April 14, 2009 / Notices
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8479 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8481 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Aneurysm Trial.
Date: April 23, 2009.
Time: 3:15 p.m. to 5:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Richard D. Crosland, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
594–0635, rc218u@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Review of NINDS PPG on
CA∧2+ Signaling in Spines.
Date: April 24, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Ernest W Lyons, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
VerDate Nov<24>2008
17:36 Apr 13, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of a Public Consultation
Meeting on Proposed Revisions to the
NIH Guidelines for Research Involving
Recombinant DNA Molecule (NIH
Guidelines)
There will be a public consultation
meeting to solicit stakeholder input
regarding the proposed revisions to the
NIH Guidelines. The meeting will be
held on Tuesday, June 23, 2009 at the
Hyatt Regency Crystal City, 2799
Jefferson Davis Highway, Arlington,
Virginia, 22202, from approximately 8
a.m. to 5 p.m.
Discussions will focus on the
proposed revisions to the NIH
Guidelines which include: (1)
Broadening the scope of the NIH
Guidelines, which currently cover
laboratory and clinical research
involving DNA molecules created via
recombinant techniques (i.e., joining of
DNA molecules), to apply to nucleic
acids that are synthesized chemically or
by other means without the use of
recombinant technology; (2) Revising
the criteria for determining when the
introduction of a drug resistance trait
into a microorganism must be reviewed
by the Recombinant DNA Advisory
Committee and approved by the NIH
Director; and (3) Changing the level of
review required for recombinant or
synthetic experiments involving more
than one-half but less than two-thirds of
the genome of certain viruses in tissue
culture as described in Section III–E–1
of the NIH Guidelines.
The Notice of Consideration of a
Proposed Action under the NIH
Guidelines was published in the
Federal Register on March 4, 2009 (74
FR 9411) and may be located at the
following link: https://oba.od.nih.gov/
rdna/rdna.html.
For further information concerning
this meeting contact Ms. Laurie
Lewallen, Advisory Committee
Coordinator, Office of Biotechnology
Activities, Office of the Director,
National Institutes of Health, 6705
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Rockledge Drive, Room 750, Bethesda,
MD 20892–7985, 301–496–9838,
lewallenl@od.nih.gov.
The meeting will be open to the
public, with attendance limited to the
space available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed above in
advance of the meeting.
A draft agenda and additional
information for the meeting will be
posted on the OBA Web site: https://
oba.od.nih.gov/rdna/rdna.html.
Background and supplemental
information may also be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov.
Dated: April 8, 2009.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology
Activities, National Institutes of Health.
[FR Doc. E9–8478 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Research Sites To
Measure Composition of Sealed Area
Atmosphere in Coal Mines
AGENCY: National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice.
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC), is
seeking research sites to measure
composition of sealed area atmosphere
in coal mines.
NIOSH seeks to conduct scientific
studies of the composition of sealed area
atmospheres and the mechanisms of
methane accumulation within sealed
areas. Research questions to be
addressed are: (1) Whether potentially
explosive gas mixtures exist within
sealed areas, (2) how extensive such
mixtures might be, (3) how the gas
composition changes over time, (4)
whether methane layering exists, (5) the
homogeneity of the atmosphere, and (6)
how barometric pressure changes
impact the sealed atmosphere. NIOSH
will document measurements of the
composition of the sealed area
atmosphere over time, analyze the
E:\FR\FM\14APN1.SGM
14APN1
Agencies
[Federal Register Volume 74, Number 70 (Tuesday, April 14, 2009)]
[Notices]
[Pages 17201-17202]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8479]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; ``Comparative Evaluation of
Assisted Reproductive Technologies and Birth Outcomes''.
Date: May 6, 2009.
Time: 2 p.m. to 3 p.m.
Agenda: To provide concept review of proposed concept review.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review
Administrator, Division of Scientific Review, National Institute of
Child Health and Human Development, 6100 Executive Boulevard, Room
5b01, Bethesda, MD 20892-9304, (301) 435-6680,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
[[Page 17202]]
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-8479 Filed 4-13-09; 8:45 am]
BILLING CODE 4140-01-P